Anti-Inflammatory Agents/pharmacology; Chalcones/pharmacology; Enzyme Inhibitors/pharmacology; Glycyrrhizic Acid/pharmacology; Lipopolysaccharides/pharmacology; Lymphocyte Antigen 96/immunology; MAP Kinase Signaling System/drug effects; Toll-Like Receptor 4/immunology; Animals; Anti-Inflammatory Agents/chemistry; Cell Line; Chalcones/chemistry; Enzyme Inhibitors/chemistry; Glycyrrhiza uralensis/chemistry; Glycyrrhizic Acid/chemistry; Interleukin-6/immunology; Interleukin-6/metabolism; Lipopolysaccharide Receptors/immunology; Lipopolysaccharide Receptors/metabolism; Lymphocyte Antigen 96/metabolism; MAP Kinase Signaling System/immunology; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases/immunology; Mitogen-Activated Protein Kinase Kinases/metabolism; NF-kappa B/immunology; NF-kappa B/metabolism; Protein Multimerization/drug effects; Protein Multimerization/immunology; Toll-Like Receptor 4/metabolism; Tumor Necrosis Factor-alpha/immunology; Tumor Necrosis Factor-alpha/metabolism